Australian Lobbyist Group Aims for Alimta

The Asbestos Coalition, a new asbestos advocacy group, plans to lobby the Australian government to add Alimta to the Pharmaceutical Benefits Scheme.
The group consists of victims, unions, and medical professionals and aims to raise awareness about the continuing problems of asbestos exposure.

The Pharmaceutical Benefits Scheme provides subsidized medications for Australian residents and is especially valuable for patients who could not normally afford life saving drug therapies.

Alimta which costs thousands of dollars per treatment cycle has become a point of contention among activists in Australia and England where previous petitions to add the drug to subsidy lists have failed.